Ionis Pharmaceuticals Inc at Stifel Virtual Healthcare Conference Transcript
Great. Thanks very much, everybody, for those who continue to dial into the fireside chat this afternoon. I am happy to be moderating a discussion here with executives from Ionis Pharmaceuticals. With me, we have CEO, Brett Monia; and CFO, Beth Hougen, who I'm sure folks style they know quite well. Maybe we can start and just have Brett give a 3 to 5-minute overview, set the stage for Ionis' key pipeline events coming off recent progress, and then we can get into Q&A. How does that sound?
Sounds great, Paul. It's a pleasure to be here. So yes, we're very excited about Ionis and where we're headed in the future. Obviously, a lot of news this year and a lot of pipeline events.
I mean, recently, we announced several Phase IIb starts of our Factor XI program, our HBV program. And then most recently, vupanorsen with Pfizer on angiopoietin
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
